Biphasic rapamycin effects in lymphoma and carcinoma treatment

mTOR drives tumor growth but also supports T cell function, rendering the applications of mTOR inhibitors complex especially in T cell malignancies. Here we studied the effects of the mTOR inhibitor rapamycin in mouse EL4 T cell lymphoma. Typical pharmacologic rapamycin (1–8 mg/kg) significantly red...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res
Autors principals: Liu, Yang, Pandeswara, Srilakshmi, Dao, Vinh, Padrón, Álvaro, Drerup, Justin M., Lao, Shunhua, Liu, Aijie, Hurez, Vincent, Curiel, Tyler J.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5286917/
https://ncbi.nlm.nih.gov/pubmed/27737881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-1140
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars